Diseases, Conditions, Syndromes

New report shows rare disease more common than previously thought

Approximately one in forty-two thousand children are born with a disease called CDKL5 Deficiency Disorder, according to a new medical report recently published in the journal Brain and presented last month at the 13th European ...

Diabetes

Scientists identify potential way to prevent type 1 diabetes  

Researchers believe they have identified a way to prevent type 1 diabetes by restoring the immune system's natural balance. The approach may also prove effective for battling other autoimmune diseases such as lupus and eczema, ...

Psychology & Psychiatry

Antidepressants may reduce anxiety more than depressive symptoms

One of the most common antidepressants, sertraline, leads to an early reduction in anxiety symptoms, commonly found in depression, several weeks before any improvement in depressive symptoms, a UCL-led clinical trial has ...

Oncology & Cancer

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the Sept. 10 issue of the ...

Medical research

Deadly infections on the increase: Urgent need for new antibiotics

Globally, the number of deaths from infections is on the rise as more bacteria become resistant to antibiotics. New classes are desperately needed. A promising resistance inhibitor is now being developed by the research group ...

Oncology & Cancer

Salvage therapy does not up survival for progressive myeloma

(HealthDay)—For myeloma patients with progressive disease (PD) after induction therapy, deepening of response through salvage therapy is not associated with improved progression-free or overall survival, according to a ...

Medications

J&J verdict sends opioid makers a billion-dollar warning

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.

page 1 from 22